Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAP-LRTI
NCT03341273Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in lower respiratory tract infection (LRTI) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Clinical Improvement at Day 5 Visit. Started Dec 2017; status: terminated.
02
Drugs
azithromycin
03
Conditions
lower respiratory tract infection (LRTI)
Beyond the preview
Go deeper on NCT03341273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03341273.